Rockefeller Capital Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,504
| Closed | -$63K | – | 2882 |
|
|
2022
Q4 | $63K | Sell |
2,504
-80
| -3% | -$2.01K | ﹤0.01% | 2265 |
|
|
2022
Q3 | $68K | Buy |
2,584
+2,078
| +411% | +$54.7K | ﹤0.01% | 2198 |
|
|
2022
Q2 | $14K | Sell |
506
-16,086
| -97% | -$445K | ﹤0.01% | 2941 |
|
|
2022
Q1 | $571K | Buy |
16,592
+430
| +3% | +$14.8K | ﹤0.01% | 1272 |
|
|
2021
Q4 | $708K | Buy |
16,162
+3
| +0% | +$131 | ﹤0.01% | 1186 |
|
|
2021
Q3 | $819K | Hold |
16,159
| – | – | ﹤0.01% | 1072 |
|
|
2021
Q2 | $840K | Buy |
16,159
+15,209
| +1,601% | +$791K | ﹤0.01% | 999 |
|
|
2021
Q1 | $43K | Buy |
+950
| New | +$43K | ﹤0.01% | 1949 |
|